Fate Therapeutics Inc. sell StockNews.com
Start price
11.05.24
/
50%
€4.15
Target price
11.05.25
-
Performance (%)
-76.44%
End price
12.05.25
€0.98
Summary
This prediction ended on 12.05.25 with a price of €0.98. The SELL prediction by StockNews_com for Fate Therapeutics Inc. performed very well with a performance of -76.44%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | -3.562% | -3.562% | 133.326% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% |
Comments by StockNews_com for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.78
10.08.25
10.08.25
-
10.08.26
10.08.26
200.94%
11.08.26
11.08.26
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.88
28.06.25
28.06.25
-
28.06.26
28.06.26
118.77%
29.06.26
29.06.26